News Stories

Alison T. Stopeck, MD

Arizona Cancer Center physician/scientist Alison T. Stopeck, MD, is the lead author of a paper appearing in the Nov. 8 issue of the Journal of Clinical Oncology reporting on the pain reducing  and complication prevention benefits of a new drug in breast cancer patients whose disease has spread to the bone.

The Better Than Ever training and fundraising program distributed $120,000 to fund five research grants focusing on women's cancers at the Arizona Cancer Center.

Arizona Cancer Center member Laurence Hurley, PhD, has been appointed chair of the National Cancer Institute's Board of Scientific Counselors for Basic Sciences.

Joyce A. Schroeder, PhD

Dr. Joyce A. Schroeder has been named co-leader of the AZCC's Cancer Biology and Genetics Program.

Arizona Cancer Center physician Daniel Persky, MD, will discuss lymphoma as part of the Green Valley Community Lecture Series Oct. 19

Sir Bruce Ponder, MB, BChir, PhD

If you weren't able to make it to the 2010 Donald Ware Waddell Lectures on Oct. 8, you can watch videos of the scientific and public lectures.

Sir Bruce Ponder will deliver the scientific and public lectures and receive the Donald Ware Waddell award at the Arizona Cancer Center Friday.

Arizona Cancer Center Director David S. Alberts, MD, is joining the board of directors of the Associaton of American Cancer Institutes.

Arizona Cancer Center Director David S. Alberts, MD, has been selected to receive the Associaton of Community Cancer Centers' 2010 Clinical Research Award at the group's National Oncology Economics Conference in St. Louis.

The loss of a gene known as INPP5A could predict the onset and track the progression of an aggressive type of skin cancer, according to a study published today by the Arizona Cancer Center, Mayo Clinic and the Translational Genomics Research Institute (TGen).